Suven pharma can shine if it gets past the next resistance Suven Pharmaceuticals Ltd. is a bio-pharmaceutical company, incorporated on 6th November, 2018 and is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies.
Suven Pharmaceuticals Ltd CMP is 669.65. The Negative aspects of the company are High Valuation (P.E. = 46), Declining annual net profit. The company's Positive aspects No debt, zero promoter pledge, FIIs are increasing stake, MFs are increasing stake, Improving cash from operations annual.
Entry can be taken after closing above 678. Targets in the stock will be 698 and 719. The long-term target in the stock will be 742 and 768. Stop loss in the stock should be maintained at Closing below 590.
The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
